Search

WEDNESDAY, Jan. 13, 2021 (HealthDay News) — Non-Hispanic Blacks with type 1 diabetes (T1D) and confirmed COVID-19 are more likely than non-Hispanic Whites to present with diabetic ketoacidosis (DKA), according to a study published online Jan. 7 in the Journal of Clinical Endocrinology & Metabolism. Osagie Ebekozien, M.D., M.P.H., from the T1D Exchange in Boston,...

MONDAY, Oct. 19, 2020 (HealthDay News) — Pfizer will not apply for emergency authorization of its COVID-19 vaccine before the third week in November, the company’s chief executive said in a statement posted to the Pfizer website on Friday. This is a reversal from the company’s previous claims that it would apply for the approval...

Patients with multiple sclerosis or NMOSD may have more complications with the COVID-19 vaccination when compared to the general population. Although vaccination against COVID-19 provides excellent protection against severe infection, this effect may be mitigated to some degree among those taking immunomodulatory medications, including those with multiple sclerosis or neuromyelitis optica spectrum disorders (NMOSD). This...

WEDNESDAY, Oct. 7, 2020 (HealthDay News) — Records for COVID-19 hospitalizations were set Tuesday in six states — Arkansas, Montana, North Dakota, South Dakota, Wisconsin, and Wyoming. Another state, Oklahoma, had its highest number of hospitalizations since July, according to The Washington Post. Wyoming’s 36.7 percent increase since last week in its rolling seven-week average...

TUESDAY, Dec. 29, 2020 (HealthDay News) — During the COVID-19 pandemic period, there have been inequities in accessing telemedicine, according to a study published online Dec. 29 in JAMA Network Open. Lauren A. Eberly, M.D., M.P.H., from the Hospital of the University of Pennsylvania in Philadelphia, and colleagues examined whether inequities are present in telemedicine...

Patients with NMOSD have increased COVID-19 risks, as determined by this meta-analysis. Individual susceptibility to COVID-19, as well as the ultimate outcome of the disease, can vary widely depending on comorbidities. This study, published in Multiple Sclerosis and Related Disorders, sought to determine the clinical features of COVID-19 in patients with neuromyelitis optica spectrum disorder...

Sickle cell disease is associated with a fourfold increased risk for COVID-19-related hospitalization and a more than twofold increased risk for COVID-19-related death, according to a research letter published in the Annals of Internal Medicine. Ashley Kieran Clift, M.B.B.S., from the University of Oxford in the United Kingdom, and colleagues assessed the risk for COVID-19-related...

TUESDAY, March 16, 2021 (HealthDay News) — Patients with diabetic ketoacidosis (DKA) with COVID-19 have a much higher rate of mortality than patients without COVID-19, according to a research letter published online March 10 in JAMA Network Open. Francisco J. Pasquel, M.D., from the Emory University School of Medicine in Atlanta, and colleagues used individual-level...

Flu infections are increasing in the U.S., and so is the likelihood of co-infection of influenza and COVID-19. The newly coined term “flurona” has trended across social media, with many patients under the false impression that flurona is a new variant of COVID-19. Flurona is precisely what it sounds like: having flu and coronavirus at...

In the general population, Black patients tend to experience more severe disease from COVID-19 than white patients. However, few studies seek to address whether Black patients with cancer experience worse outcomes from COVID-19 than white patients with cancer. Structural racism carried out through sociodemographic factors, such as underinsurance and disproportionate access to health care, may...